DELMIA Apriso

Divi’s Laboratories Limited (Divi’s), is a pharmaceutical company headquartered in Hyderabad, India.
Divi’s is engaged in manufacturing leading generic compounds, nutraceutical ingredients and custom synthesis of APIs and intermediates for global innovator companies primarily for export to regulated markets such as US and Europe. With two manufacturing facilities, market presence across several countries and a team of 10,000 employees, Divi’s continues to innovate to bring robust techniques to facilitating sustainable manufacturing processes.

The company was founded in 1990 by Dr. Murali K Divi with research and development as its core area. Started initially as a Research and Development Center, it expanded and focused on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates, providing complete turnkey solutions and consulting to the domestic pharmaceutical industry.

DRK Pharma Solutions is a premier solution provider to the pharmaceutical and biopharmaceutical industries in the areas of product development, clinical research and contract manufacturing through highly experienced professionals, world-class infrastructure and focus on timely delivery.

DRK Pharma Solutions provide process/product development and manufacturing solutions through collaborative partnership models. We also have broad range of proprietary generics products available for technology transfer.

DRK Pharma Solutions offers end-to-end clinical trial services to the global Bio/Pharmaceutical industries.

DRK Pharma Solutions also offers Contract Manufacturing services through its vast network of contract manufacturing organizations in Europe and Asia that offers a full portfolio of services for sterile and non-sterile products from pre-formulation to commercial supply worldwide.

Hangzhou AllTest Biotech Co., Ltd is located in 550#，Yinhai Street, Baiyang District, Hangzhou Economic-Technological Development Area, the company registered capital of 15 million RMB. The company’s total construction area is about 3200 M2. The company holds strong ability of scientific research and innovative technology. AllTest Biotech leads the development frontier of biological technologies such as monoclonal antibody-colloidal gold and latex technique, gene engineering, compound antigen and immunoassay.

AllTest Biotech is thriving on design, development, manufacturing and sales of the lateral flow rapid IVD products and food safety test product. The product is broadly recognized in the international market for its rapid, convenience and accurateness. AllTest Biotech will strive to become the leader and pioneer in the diagnostic industry field of China and the world.

Indus Biotech is a consumer healthcare products research and manufacturing company headquartered in Pune, India. Founded in 1997, Indus Biotech focuses on identifying and developing a new generation of products for Autoimmune, CNS, Infectious and Lifestyle diseases.

Currently, we have multiple clinically tested and marketed products in exercise physiology and an impressive pipeline of innovative products that are ready-to-launch. Our innovative discovery and development paradigm generates safe and efficacious products from food-chain raw materials that can effectively address the continuum of consumer healthcare spanning preservation of health, performance enhancement, risk reduction for disease susceptibility and therapeutics.

Indus Biotech implements a unique business model that facilitates short-term revenue generation, while enabling long-term value creation.

Founded in 2004, Pharmaron is a cutting-edge, fully integrated pharmaceutical R&D service platform supporting the life science industry. The company has invested in its people and facilities and established its comprehensive service offerings throughout the pharmaceutical R&D lifecycle. With operations in China, the US and the UK staffed by more than 11,000 employees, Pharmaron has an excellent track record in delivering end-to-end R&D solutions to its partners globally and enabling them to accelerate their novel drug discovery and development process.

Pharmaron is a contract research organization (CRO).

Services:
* Synthetic, medicinal and analytical chemistry services
* Biology services
* DMPK services
* Pharmacology services
* Drug safety assessment services
* Radiochemistry and isotopically labelled metabolism services
* Chemical & pharmaceutical development services
* Clinical development services

www.pharmaron.com

CRO - Contract Research Organization
Library Synthesis
CADD
Bioorganic Chemistry
Discovery Process Chemistry
Radiolabelled Chemical Synthesis
ChemInformatics
in vitro Biology
in vitro Screening
Structural Biology
in vivo Pharmacology
Animal Disease Models
ex vivo Pharmacology
Biomarkers
in vitro ADME
in vivo PK
PKPD
QA
Regulatory Affairs
Discovery Biologics
Process Chemistry
API Manufacturing
Material Science
Formulation Development
Drug Product Manufacturing
Toxicology
Safety Pharmacology
Genetic Toxicology
DART
Pathology
Immunotoxicity
Bioanalytical
14C / Carbon-14 Radiosynthesis
3H / Tritium Radiosynthesis
QWBA
mARG
Clinical AME
Mass Balance
Metabolite Profiling
Microdosing Phase 0
Absolute Bioavailability
DDI
First-in-Human (FIH)
Thorough QT(TQT)
Ethnobridging